Jonca Bull, MD

Dr. Jonca Bull has more than 20 years of experience in the public and private sector addressing clinical research and regulatory compliance. She has worked working across a range of therapeutic areas and indications, and her strengths include clinical trial strategy, program, and policy development.

Previously, Dr. Bull served as Vice President and Strategic Regulatory Advisor for Global Product Development at PPD. Prior to joining PPD, Dr. Bull served as an assistant commissioner at FDA, with focus on clinical trials and demographic inclusion; vice president for US/North American regulatory policy for Novartis Pharmaceuticals; and director of clinical regulatory policy for Genentech. From 1994 to 2005, Dr. Bull held various senior leadership roles with the FDA across various disease areas and programs, including Acting Division Director of the Division of Anti-Inflammatory, Analgesic and Ophthalmic Drugs, addressing pre- and post-marketing issues. From 1982 to 1994, she cared for patients in a large medical/surgical practice in the Washington metro area. She is a diplomat of both the American Board of Ophthalmology and the National Board of Medical Examiners.

Dr. Bull holds an undergraduate degree from Princeton University and a medical degree from Duke University. She completed residencies in general medicine and ophthalmology at George Washington University Hospital in Washington, DC, where she also serves as an assistant clinical professor. She is a recipient of a 2017 Year of Women Award in recognition of great accomplishment to the field of ophthalmology by Women in Ophthalmology.